Common Stock, par value $0.0001 per share
- Symbol
- VBIO
- Exchange
- NASDAQ
- Classification
- COMMON
- Status
- Current
Current Report · Items 1.01, 3.02, 8.01 · 8-K
Valion Bio, Inc.
VBIONASDAQEQUITYCurrent
Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities · Other Events
Item 8.01 Other Events. As of the date hereof, the Company has, in connection with the development and commercialization process, achieved its first milestone, relating to the validation of current inventory of materials for distribution and sales.…
Company context
We are an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012, or JOBS Act. An emerging growth company may take advantage of specified reduced reporting requirements that are otherwise generally applicable to public companies. As a result:
Current securities
Historical securities (1)
Recent company filings
- Entry into a Material Definitive Agreement · Unregistered Sales of Equity SecuritiesNov 9, 2026
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsNov 5, 2026
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Other EventsNov 2, 2026
- Other EventsOct 29, 2026
- Entry into a Material Definitive Agreement · Unregistered Sales of Equity SecuritiesOct 27, 2026
Registered securities in this filing
Valion Bio, Inc. · 8-K · Filed 2026-08-06
Disclosure sections
Item 8.01Item 8.01 - Other Events
Item
8.01 Other Events.
As of the
date hereof, the Company has, in connection with the development and commercialization process, achieved its first milestone, relating
to the validation of current inventory of materials for distribution and sales. In connection therewith, the Company is obligated to make
a milestone payment of $750,000 (the “Milestone Payment”), in accordance with the terms of the A&R License Agreement.
The foregoing
description of the Company’s obligations related to the Milestone Payment does not purport to be complete and is qualified in its
entirety by reference to the full text of the A&R License Agreement, a copy of which is filed as Exhibit 10.1 to the A&R 8-K and
is incorporated herein by reference.